Viewing Study NCT04503902


Ignite Creation Date: 2025-12-25 @ 3:43 AM
Ignite Modification Date: 2025-12-26 @ 2:29 AM
Study NCT ID: NCT04503902
Status: UNKNOWN
Last Update Posted: 2022-11-29
First Post: 2020-08-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module